Press Releases

The global injectable drug delivery device technologies market was valued at approximately $10.2bn in 2012 and is expected to grow at a CAGR rate of 11% to $17.2bn by 2017. This comes as no surprise as...

The new, extremely compact MCP 100 polarimeter now helps anyone working with optically active substances to reach all required targets in a fully traceable fashion. Its high quality is a given: the instrument is launched by technology leader Anton...

Ferrer, a privately-held Spanish pharmaceutical company today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in the United States of America, Puerto Rico and the U.S. Virgin Islands to Medimetriks Pharmaceuticals Inc. Under the...

Provepharm, a French company specialized in the development of pharmaceutical applications announces that Daiichi Sankyo, Co. Ltd., a global pharmaceutical firm, has filed an NDA  For the development and marketing of the injectable Methylene Blue medicinal...

This appointment makes the Montreal site attractive to North American clients and boosts CiToxLAB’s expertise in preclinical development and regulatory affairs. CiToxLAB, a leading CRO in the field of non-clinical research, announces today that John...

Adocia’s BioChaperone Combo is the first product combining insulin Glargine with a fast-acting insulin analogPhase I/II clinical trial demonstrates proof of concept in patients with type 1 diabetes, showing that BioChaperone Combo acts faster and longer than Humalog Mix...

BANGKOK Feb. 25 2014 - UBM Asia is pleased to announce the launch of ASEANbeauty the only beauty trade event supported by the Thai Cosmetics Manufacturers Association. This is to be the premier international beauty trade show for South...